Dana Huskens, PhD

PhD, Research Project Leader
Synapse research insitute

Dana Huskens, PhD, Research Project Leader at Synapse, was born in Flanders and studied at KU Leuven. After a master’s degree in Biomedical Sciences, she defended her doctoral thesis in 2010 with a research topic on HIV inhibitors in the early stages of infection. She continued with a 3-year post-doc at the same university, specialising in the same field, studying the mechanisms of action and development of resistance of HIV inhibitors. On joining the Synapse Research Institute in the Netherlands in 2013, she left her native Belgium (and HIV) behind to focus on thrombin generation. Her first project concerned the optimisation and clinical validation of a method for measuring thrombin in whole blood. She is now involved in various fields of research on new tests relating to platelet function, plasmin generation, fibrin degradation products and von Willebrand factor.

Presentation(s):

PB0086 - Haemostatic differences between SARS-CoV-2 PCR-positive and -negative patients at the time of hospital admission
Sunday, July 10, 2022
6:30 PM – 7:30 PM
PB0087 - Hyperresponsive platelets and a reduced platelet granule release capacity is associated with severity of COVID-19 symptoms and with increased mortality.
Sunday, July 10, 2022
6:30 PM – 7:30 PM
PB0780 - Patients with multiple myeloma have an increased prevalence of acquired platelet secretion defects and a disbalanced whole blood thrombin generation profile
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB0862 - Platelet activation via glycoprotein VI initiates thrombin generation: a potential role for platelet-derived factor IX?
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB1030 - Erythrocytes impair the anticoagulant function of the protein C system in whole blood thrombin generation.
Tuesday, July 12, 2022
6:30 PM – 7:30 PM
PB1043 - Complementary roles of red blood cells and platelets in high-throughput whole-blood thrombin generation
Tuesday, July 12, 2022
6:30 PM – 7:30 PM